# The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder

> **NCT00107120** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 312 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00107120
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2007-05
- **Final completion:** —
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2012-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107120, "The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00107120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*